Last edition
News about " investigational monoclonal antibody"
CSL, Alentis Sign Global Deal to Develop Lixudebart
CSL and Alentis enters an exclusive global collaboration to advance lixudebart across kidney and liver diseases.
Investigational Monoclonal Antibody | 06/10/2026 | By News Bureau
Merck Reports Positive Phase 2b Tulisokibart Results in Hidradenitis Suppurativa
Merck reported Phase 2b results for investigational tulisokibart in patients with moderate to severe hidradenitis suppurativa.
Investigational Monoclonal Antibody | 01/10/2026 | By News Bureau | 107
Damora Therapeutics Launches Global Phase 1/1b Trial of DMR-001 for mutCALR-Driven Blood Cancers
Damora Therapeutics initiates the global CLARITY-101 clinical trial to assess DMR-001, a novel mutation-targeted therapy designed to address the underlying cause of mutCALR-driven blood disorders.
Investigational Monoclonal Antibody | 07/08/2026 | By News Bureau | 219
Duvakitug Shows Durable Efficacy in Ulcerative Colitis and Crohn's Disease in Long-Term Study
Long-term extension data show sustained remission and endoscopic response with duvakitug in ulcerative colitis and Crohn’s disease, strengthening its position as a potential next-generation TL1A therapy.
Investigational Monoclonal Antibody | 18/02/2026 | By News Bureau | 500
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy